LUMENSIA SENSORS SL

Their core work

Lumensia Sensors is a Valencia-based SME that develops photonic biosensor platforms — compact devices that use light-based detection (plasmonics, interferometry, quantum dots) to identify biological targets such as disease markers, allergens, and pathogens. Their work spans from integrated photonic chip design to full analytical device automation, delivering sensor solutions that can be deployed outside traditional laboratories. They bridge nanophotonics research and real-world diagnostic applications in food safety and animal health.

What they specialise in

How they've shifted over time

Lumensia started with diagnostic biosensors for specific medical and veterinary applications — drug allergy diagnosis (COBIOPHAD, 2016) and swine disease field testing (SWINOSTICS, 2017). From 2020 onward, their focus shifted decisively toward food safety and advanced nanophotonics, with SaPher tackling multi-allergen detection and GRACED pushing into plasmo-photonic multiplexing for agri-food value chains. The trajectory shows a move from single-analyte diagnostics toward multiplexed, miniaturized platforms serving the food industry.

Lumensia is converging on ultra-compact, multiplexed photonic sensors for food safety — expect them to pursue agri-food supply chain monitoring and rapid on-site allergen testing next.

How they like to work

Lumensia operates exclusively as a specialist participant, never coordinating projects but contributing deep photonic sensor expertise to consortia. With 37 unique partners across 15 countries from just 4 projects, they work in large, internationally diverse consortia typical of Innovation Actions. This pattern suggests they are a sought-after technology component provider — teams recruit them for their specific sensor capabilities rather than Lumensia assembling its own consortia.

Lumensia has built a broad European network of 37 partners across 15 countries through just four projects, indicating they consistently join large, multi-national consortia. No obvious geographic clustering — their partnerships span widely across the EU.

What sets them apart

Lumensia occupies a rare niche at the intersection of integrated photonics hardware and applied biosensing for food and agriculture — most photonics SMEs stay in telecoms or general instrumentation. Their progression from single-target diagnostics to multiplexed nanophotonic platforms shows they can deliver increasingly sophisticated sensor technology at compact form factors. For consortium builders, they offer a ready-made photonic biosensor component partner with proven experience translating lab photonics into field-deployable devices.

Highlights from their portfolio

• SaPher
  Largest funding (EUR 689,885) — a disruptive nanophotonic platform for simultaneous multi-allergen analysis, representing Lumensia's most ambitious technical scope.
• GRACED
  Most advanced photonics work: combines plasmonics, quantum dots, and on-chip light generation into ultra-compact bimodal multiplexing sensors for agri-food applications.
• SWINOSTICS
  Demonstrates versatility — field-deployable biosensors covering six different swine diseases (ASF, PRRS, CSF, PCV2, PPV, SIV) in a single diagnostic toolbox.